European Parliament
Diogo Feio  (PPE ),
in writing.
(PT)
As in previous years, several issues have again arisen in relation to the normal operation of the European Medicines Agency, in particular, the existence of possible conflicts of interest, and the legality and regularity of the underlying transactions. In view of this, I would congratulate the rapporteur on her decision to postpone discharge, which I support, and I would reiterate that it is vital that all of the EU institutions and agencies follow and respect the same principles of good management and transparency.

